Genetic testing for von Willebrand disease: The Canadian experience

Seminars in Thrombosis and Hemostasis

Volumn 32, Issue 5, 2006, Pages 546-552

  James, Paula ^a   Lillicrap, David ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Genetics; Mutations; Polymorphisms; Von Willebrand disease (vWD)

Indexed keywords

VON WILLEBRAND FACTOR;

CANADA; DIAGNOSTIC PROCEDURE; FEASIBILITY STUDY; GENE; GENE AMPLIFICATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC TRAIT; GENETIC VARIABILITY; HEMOSTASIS; HUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TECHNOLOGY; VON WILLEBRAND DISEASE; VWF GENE;

CANADA; DIAGNOSTIC TECHNIQUES AND PROCEDURES; GENETICS; HUMANS; MUTATION; PROMOTER REGIONS (GENETICS); VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 33746648140     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-947870     Document Type: Review

References (25)

1. Sadler JE, Shelton-Inloes BB, Sorace JM, et al. Cloning and characterization of two cDNAs coding for human von Willebrand factor. Proc Natl Acad Sci USA 1985;82:6394-6398
2. Ginsburg D, Handin RI, Bonthron DT, et al. Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization. Science 1985; 228:1401-1403
3. Lynch DC, Zimmerman TS, Collins CJ, et al. Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method. Cell 1985;41:49-56
4. Verweij CL, deVries CJM, Distel B, et al. Construction of cDNA coding for human von Willebrand factor using antibody probes for colony screening and mapping of the chromosomal gene. Nucleic Acids Res 1985;13:4699-4717
5. Mancuso DJ, Tuley EA, Westfield LA, et al. Structure of the gene for human von Willebrand factor. J Biol Chem 1989; 264(33):19514-19527
6. Titani K, Kumar S, Takio K, et al. Amino acid sequence of human von Willebrand factor. Biochemistry 1986;25:3171-3184
7. Mancuso DJ, Tuley EA, Westfield LA, et al. Human von Willebrand factor gene and pseudogene: structural analysis and differentiation by polymerase chain reaction. Biochemistry 1991;30:253-269
8. Stephens JC, Schneider JA, Tanguay DA, et al. Haplotype variation and linkage disequilibrium in 313 human genes. Science 2001;293:489-493
9. Livingston RJ, von Niederhausern A, Jegga AG, et al. Pattern of sequence variation across 213 environmental response genes. Genome Res 2004;14:1821-1831
10. Zhang ZP, Blomback M, Egberg N, Falk G, Anvret M. Characterization of the von Willebrand factor gene (VWF) in von Willebrand disease type III patients from 24 families of Swedish and Finnish origin. Genomics 1994;21:188-193
11. Baronciani L, Cozzi G, Canciani MT, et al. Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients. Blood Cells Mol Dis 2003;30:264-270
12. University of Sheffield. ISTH SSC VWF Database. Available at: http://www.shef.ac.uk/vwf/. Accessed on February 15, 2006
13. Lyons SE, Bruck ME, Bowie EJW, Ginsburg D. Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations. J Biol Chem 1992;267:4424-4430
14. O'Brien LA, Sutherland JJ, Weaver DF, Lillicrap D. Theoretical structural explanation for Group I and Group II type 2A von Willebrand disease mutations. J Thromb Haemost 2005;3:796-797
15. James PD, O'Brien LA, Hegadorn CA, et al. A novel type 2A von Willebrand factor mutation located at the last nucleotide of exon 26 (3538G>A) causes skipping of 2 nonadjacent exons. Blood 2004;104:2739-2745
16. Hillery CA, Mancuso DJ, Evan SJ, et al. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets. Blood 1998;91:1572-1581
17. Mazurier C, Hubert L. Type 2N von Willebrand disease. Curr Hematol Rep 2005;4:350-358
18. Hilbert L, d'Oiron R, Fressinaud E, Meyer D, Mazurier C. First identification and expression of a type 2N von Willebrand disease mutation (E1078K) located in exon 25 of von Willebrand factor gene. J Thromb Haemost 2004;2: 2271-2273
19. Abildgaard CF, Suzuki Z, Harrison J, Jefcoat K, Zimmerman TS. Serial studies in von Willebrand's disease: variability versus "variants." Blood 1980;56:712-716
20. James P, Paterson AD, Notley CRP, et al. Understanding the genotype/phenotype link in type 1 von Willebrand Disease (VWD): results from the Canadian Type 1 VWD Study. J Thromb Haemost 2005;3(suppl 1; abst OR280)
21. Eikenboom J, Van Marion V, Putter H, et al. Linkage analysis of von Willebrand disease type 1 phenotype, von Willebrand factor levels and bleeding symptoms with Von Willebrand factor gene locus in the European Multicenter MCMDM-1VWD Study. J Thromb Haemost 2005;3(suppl 1; abst OR279)
22. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987;69:1691-1695
23. Mohlke KL, Purkayastha AA, Westrick RJ, et al. Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase. Cell 1999;96:111-120
24. James PD, Notley CRP, Hegadorn C, et al. The mutational spectrum of type 1 Von Willebrand Disease (VWD): results from the Canadian Type 1 VWD Study. J Thromb Haemost 2005;3(suppl 1; abst PO264)
25. Goodeve A, Hashemi M, Castaman GC, et al. Mutation profile in patients diagnosed with type 1 von Willebrand disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD). J Thromb Haemost 2005;3(suppl 1; abst OR281)